IBT
BEAM icon

International Biotechnology Trust’s Beam Therapeutics BEAM Stock Holding History

International Biotechnology Trust’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$565K Hold
23,500
– – 0.19% 58
2023
Q2 		$750K Hold
23,500
– – 0.23% 52
2023
Q1 		$718K Hold
23,500
– – 0.2% 55
2022
Q4 		$919K Hold
23,500
– – 0.28% 52
2022
Q3 		$1.12M Buy
23,500
+22,590
+2,482% +$1.29M 0.36% 50
2022
Q2 		$23.5K Buy
+910
New +$36.2K 0.25% 62

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

International Biotechnology Trust's BEAM Position: Q3 2023 in Review

International Biotechnology Trust held its Beam Therapeutics (BEAM) position steady in Q3 2023 at 23,500 shares worth $565K. The position accounts for 0.19% of the portfolio, ranked #58.

International Biotechnology Trust first reported a position in BEAM in Q2 2022 and has held it in 6 quarters since. The position peaked at $1.12M in Q3 2022. 194 funds tracked by Wall St. Rank hold BEAM as of Q3 2023.

  • International Biotechnology Trust held 23,500 shares of Beam Therapeutics worth $565K as of Q3 2023.
  • International Biotechnology Trust left its Beam Therapeutics share count unchanged in Q3 2023.
  • Beam Therapeutics made up 0.19% of International Biotechnology Trust's portfolio in Q3 2023, its #58 holding.
  • International Biotechnology Trust first reported a position in Beam Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • International Biotechnology Trust's Beam Therapeutics position peaked at $1.12M in Q3 2022.
  • 194 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.